Clinical Trials Browser

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Nasopharyngeal Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Thyroid Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT05786716 2025-12-02

DETERMINE

Phase 2/3 Recruiting

30 enrolled

DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther hematologic neoplasmThoracic

Urinary Bladder Neoplasms, Gallbladder Neoplasms, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Skin Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms

NCT05770037 2025-11-24

DETERMINE

Phase 2/3 Recruiting

30 enrolled

CNSGenitourinaryLymphoidOther hematologic neoplasm

Carcinoma, Renal Cell, Lymphoma, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neuroblastoma, Lymphoma, Large-Cell, Anaplastic, Hematologic Neoplasms

NCT06861192 2025-11-18

Clinical Study of Fasudil Hydrochloride and PD1 Inhibitor Combined With Androgen Deprivation in Neoadjuvant Therapy of Prostate Cancer

Phase 2/3 Recruiting

83 enrolled

Genitourinary

Prostate CA

NCT04263025 2025-10-22

AMNIOX CORD Study - Radical Prostatectomy With and Without Cryopreserved Umbilical Cord Allograft

Phase 2/3 Recruiting

100 enrolled

Genitourinary

Prostatic Neoplasms

NCT07209878 2025-10-07

68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI

Phase 2/3 Recruiting

100 enrolled

Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT06124976 2025-09-15

Multicenter Clinical Trial of ST-02 for Ablation of Upper Tract Urothelial Carcinoma

Phase 2/3 Recruiting

70 enrolled

Genitourinary

Urothelial Carcinoma of the Renal Pelvis and Ureter

NCT06537154 2025-07-30

NEO-BLAST

Phase 2/3 Recruiting

688 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT05920343 2025-07-10

PREVENT-GU

Phase 2/3 Recruiting

120 enrolled

Classical hematologyGenitourinary

Urogenital Neoplasms, Urologic Neoplasms, Venous Thromboembolism

NCT06879145 2025-06-18

Clinical Study on the Treatment of MIBC Patients With SHR-A2102 Injection Combined With Adebrelimab (SHR-1316)

Phase 2/3 Recruiting

840 enrolled

Genitourinary

Muscular Invasive Bladder Cancer (MIBC)

NCT06972511 2025-05-15

Maximal Tumor Eradication for Oligometastatic Prostate Cancer

Phase 2/3 Recruiting

120 enrolled

Genitourinary

Oligometastatic Prostate Cancer

NCT06493552 2025-04-03

Modular Trial of sEphB4-HSA in EphrinB2-High Solid Tumors

Phase 2/3 Recruiting

700 enrolled

Genitourinary

Carcinoma, Transitional Cell

NCT05381103 2025-01-31

PSMA-PET to Guide Prostatectomy

Phase 2/3 Recruiting

288 enrolled

Genitourinary

Prostatic Neoplasms

NCT03755739 2024-06-25

Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors

Phase 2/3 Recruiting

200 enrolled

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Kidney Neoplasms, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms

NCT04242017 2023-12-13

LOBSTER

Phase 2/3 Recruiting

394 enrolled

Genitourinary

Prostatic Neoplasms

NCT04654338 2023-06-27

EARTH

Phase 2/3 Recruiting

30 enrolled

Genitourinary

Prostatic Neoplasms